Dulaglutide injection should be given subcutaneously in the abdomen, thigh or upper arm once e every week at any time of the day.
The initial dose is 0.75 mg once a week. The dose can be increased to 1.5 mg for further lowering of blood glucose.
Injection: 0.75 mg/0.5 mL solution in a single-dose pen or prefilled syringe
Injection: 1.5 mg/0.5 mL solution in a single-dose pen or prefilled syringe for treating adults with type 2 diabetes
• If there is an allergy to dulaglutide or any other product components
• With a personal or family history of thyroid carcinoma or in patients with type 2 Multiple Endocrine Neoplasia syndrome (a hormonal disorder)
• As the main treatment option for patients inadequately controlled on diet and exercise.
• With pancreatitis , alternate treatment should be considered.
• For the treatment of type 1 diabetes mellitus or severe diabetes like diabetes ketoacidosis
• With pre-existing severe gastrointestinal disease.
The initial dose is 0.75 mg once a week. The dose can be increased to 1.5 mg for further lowering of blood glucose.
Dosage & When it is to be taken
Dulaglutide is available as:Injection: 0.75 mg/0.5 mL solution in a single-dose pen or prefilled syringe
Injection: 1.5 mg/0.5 mL solution in a single-dose pen or prefilled syringe for treating adults with type 2 diabetes
When it is not to be taken (Contraindications)
Dulaglutide should not be used in patients:• If there is an allergy to dulaglutide or any other product components
• With a personal or family history of thyroid carcinoma or in patients with type 2 Multiple Endocrine Neoplasia syndrome (a hormonal disorder)
• As the main treatment option for patients inadequately controlled on diet and exercise.
• With pancreatitis , alternate treatment should be considered.
• For the treatment of type 1 diabetes mellitus or severe diabetes like diabetes ketoacidosis
• With pre-existing severe gastrointestinal disease.
